Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenoid Cystic Cancer
Research on adenoid cystic cancer discussed by scientists at Mayo Clinic
October 7th, 2008
"Salivary gland-type lung carcinomas are uncommon neoplasms of the lung, the two most common being adenoid cystic carcinoma and mucoepidermoid carcinoma. Although they usually have an indolent behavior, adenoid cystic carcinomas can be more aggressive, with 5-year survival as low as 55%," researchers in the United States report. "Unfortunately, these tumors do not respond well to chemotherapy. In contrast to the most common subtypes of lung carcinomas, epidermal growth factor receptor studies have not been carried out in this group of tumors. Herein we report a series of 24 cases ( 12 adenoid cystic and 12 mucoepidermoid carcinomas) tested for epidermal growth factor...
Source: Cancer Weekly (2008-10-07)
|
